Robert Hayashi, MD
Director of Hematology/Oncology
St. Louis Children’s Hospital
- Co-founded Late Effects Clinic at St. Louis Children’s Hospital, one of only 30 NCI-designated sites to study the lifetime effects associated with childhood cancer.
- Director of the Bone-Marrow Transplantation Unit at St. Louis Children's Hospital: one of a select few pediatric facilities nationwide certified to perform transplants from unrelated donors.
- Attending physician in Hematology/Oncology and General Pediatrics at St. Louis Children’s Hospital. Dr. Hayashi specializes in pediatric hematology, oncology and transplantation, and also is Associate Professor of Pediatrics; Division Director of Hematology and Oncology at Washington University School of Medicine.
Notable Quotes from Dr. Hayashi
Dr. Hayashi on the challenge and need to care for pediatric cancer survivors into adulthood:
“Thirty years ago only 30 percent of children diagnosed with cancer survived into adulthood. Today, the survival rate has grown to 80 percent. That remarkable increase has presented pediatric oncologists with a new challenge—caring for these cancer survivors into adulthood.”
Dr. Hayashi on recognizing the “late effects” of pediatric cancer treatment:
“The intense regimens that enable us to cure our patients are also responsible for medical difficulties that will follow them throughout their lives. The nature of these ‘late effects’ vary broadly depending on the type of therapy patients receive and how old they are at the time of treatment. Sometimes families come to us after first seeking treatment through conventional medical referrals because they don’t realize the problems their child is experiencing are directly or indirectly related to cancer treatment.”